An interventional study of ASSIP in Suicidality and Suicide, Attempted, sponsored by University of Zurich. Completed at 1 site in Switzerland. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-08.
Sponsored by University of Zurich · Not applicable, Interventional, and Treatment
"Attempted Suicide Short Intervention Program" (ASSIP) is a brief psychotherapy intervention after suicide attempts in psychiatric patients. The study aims to analyse the efficacy in a controlled trial by comparing number of patients with suicide attempts in a control group with treatment as usual and an intervention group with treatment as usual and ASSIP intervention.
Further, the study aims at indentifying electrophysiological, sociodempgraphical or smartphone-derived parameters for prediction of further suicide attempts.
Suicide is the second leading cause of death among the 14-40 years old in Switzerland. Every year around 800'000 people all over the world die due to suicide (WHO, 2017). Preceding suicide attempts and self-harming behaviour have been found to be the main risk factor for completed suicide. The "Attempted Suicide Short Intervention Program" (ASSIP) has been designed to reduce further suicide attempts and suicide in patients after a suicide attempt. This study aims to replicate the findings of another study (Gysin-Maillart, Schwab, Soravia, Megert, \& Michel, 2016) that show the efficacy of ASSIP. Further, it is intended to identify predictors for positive treatment outcome, i.e. a reduction of further suicide attempts in patients that had already committed a suicide attempt.
Main objective:
Assessment of efficacy of ASSIP by comparison of the number of patients that committed suicide attempts in the intervention (ASSIP) and the control group.
Secondary objectives:
Identification of electrophysiological representations of suicidality (patient group, control group, healthy controls).
701 studies on the registry are indexed under Suicide; 183 are open to participants now.
This study's enrollment of 100 is close to the median of 104 across 560 interventional studies indexed under Suicide.
Browse Suicide studies →University of Zurich is the lead sponsor of 1,030 studies on the registry; 130 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
ASSIP psychotherapy intervention + treatment as usual (TAU)
Other: ASSIP
Treatment as usual
Three PSychotherapy Sessions plus after 3/6/9/12 months individualized letters
Also known as: Attempted Suicide Short Intervention Program
suicide/attempted suicide
number of patients with attempted suicide or suicide
Time frame: 12 months
Number of toal suicide attempts
Number of suicide attempts after 3/6 months/ one year (not a binary measure, each new attempt counts)
Time frame: 3,6,12 months
Hospitalization rates
Hospitalization rates and days and approximated treatment costs after one year
Time frame: 12 months
EEG-vigilance
Electrophysiological wakefulness regulation as assessed via "VIGALL" algorithm in responders and non-responders
Time frame: baseline
ECG Heart Rate Variability
Electrophysiological heart rate variability (Total Power) associated with suicidality
Time frame: baseline
Plan to share: Undecided
This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Zurich